Esketamine

This classification denotes an anesthetic agent with the molecular formula C13H16ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50LFG02TXD, chemically known as cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8ci) but generally known as esketamine, which bears US NIH Compound Identifier 3821. European Medicines Agency schedules Esketamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25825. The term ESKETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules esketamine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule esketamine under HS 29223900 and SITC 51463. As of Q4 2014, ESKETAMINE remains the US FDA Preferred Term for this commodity. Esketamine bears US NLM identifiers UMLS ID C2825616 and NCI Concept Code C81400. SMILES: CLC1C(C2(NC)CCCCC2=O)CCCC1.